Compass Therapeutics (CMPX) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.92% |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | 65.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.69% |
| Dec 31, 2025 | -71.10% |
| Sep 30, 2025 | -75.86% |
| Jun 30, 2025 | -77.87% |
| Mar 31, 2025 | -86.29% |
| Dec 31, 2024 | -60.69% |
| Sep 30, 2024 | -53.09% |
| Jun 30, 2024 | -50.83% |
| Mar 31, 2024 | -45.81% |
| Dec 31, 2023 | -42.69% |
| Sep 30, 2023 | -38.47% |
| Jun 30, 2023 | -34.92% |
| Mar 31, 2023 | -35.90% |
| Dec 31, 2022 | -30.14% |
| Sep 30, 2022 | 19.02% |
| Mar 31, 2022 | 80.30% |
| Dec 31, 2021 | 99.20% |
| Sep 30, 2021 | -40.65% |
| Dec 31, 2020 | -69.98% |